The General Meeting decides on the remuneration of the Board of Directors and the Board of Directors in turn decides on the CEO’s remuneration and other benefits in accordance with Nanoform’s remuneration principles.
Nanoform’s Board of Directors has adopted Nanoform’s remuneration policy on 17 March 2022. The remuneration policy was presented to the General Meeting of the shareholders on 12 April 2022 and again to the General Meeting of the shareholders on 21 April 2026.
The current remuneration principles as adopted by the Board of Directors and presented to the General Meeting may be found here.
The Company’s general remuneration principles apply to the entire personnel. The key principles of the Company’s remuneration are transparency, market-orientation and remuneration based on good performance of both the individual employees and the Company.
Remuneration of the Company´s personnel is based on a total remuneration, which may among other things include both variable and fixed components of remuneration as well as personnel benefits. Remuneration of the personnel in accordance with the remuneration principles may consist of the following components:
- Basic salary and employee benefits in compliance with the local market practices, laws and regulations.
- The annual incentive plan is intended to guide the performance of an individual and the organisation as well as to support rapid implementation of strategic projects. The performance of the Company is emphasised in the annual incentive plan.
- The long-term incentive plan is intended to commit key persons to the Company and at harmonising their interests with those of shareholders and are only based on the financial performance of the Company.
The remuneration of the personnel, the CEO and the Board are regularly evaluated in relation to general market practices for persons acting in equivalent positions.
The Annual General Meeting 2026 decided that the fees to the Board of Directors should be paid in the amount of:
- EUR 6,400 per month for the Chairman of the Board of Directors;
- EUR 4,000 per month for the other members of the Board of Directors;
- EUR 2,000 per month for the Chairman of the Audit and Compensation Committee; and
- EUR 1,200 per month for the other members of the Audit and Compensation Committee.
The Annual General Meeting 2026 resolved that, as recommended by the Board of Directors, no remuneration is to be paid to a board member who is employed by the company. The Annual General Meeting 2026 resolved further that the aforementioned remuneration will be paid in one (1) instalment during the term, after the publication of the interim report for the period 1 January 2026 – 31 March 2026. According to the Remuneration Policy adopted by the Company, the members of the Board of Directors are recommended to hold a certain number of shares in the Company. The Company recommends each board member to use approximately 50% of the remuneration to subscribe for shares in the Company. Therefore, the members of the Board of Directors are offered a possibility to subscribe for shares at a price corresponding to volume-weighted average share price over ten (10) trading days following the publication of the interim report of the Company for 1 January 2026 – 31 March 2026.
The description of remuneration and personnel benefits of the key management personnel, including the CEO Edward Hæggström and CFO Albert Hæggström, who is also a member of the Board, may be found in the Remuneration Report to be published in connection with the Financial Statements.